Inflammatory bowel diseases such as ulcerative colitis (UC) may be complicated by several extraintestinal manifestations. These involve joints, skin, eyes and less commonly lungs and heart. Myocarditis may result from the toxic effect of drugs (ie, mesalazine) commonly used for the treatment of UC or due to infections (eg, Coxsackieviruses, enteroviruses, adenovirus). Here, we report a case of a 26-year old man affected by UC and complicated by two episodes of myocarditis. Both episodes occurred during two severe exacerbations of UC. However, in both cases the aetiology of myocarditis remains uncertain being ascribable to extraintestinal manifestation, drug toxicity or both
Copyright © 2015 Michele Sorleto et al.This is an open access article distributed under the Creative...
Ulcerative colitis is a chronic inflammatory disease affecting mainly the colon and presenting with ...
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first...
Inflammatory bowel diseases such as ulcerative colitis (UC) may be complicated by several extraintes...
Inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, may be associated wit...
Myocarditis can be idiopathic or arise in response to numerous systemic insults. Myocarditis occurri...
Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoi...
A 25-year-old male with a background of ulcerative colitis presented with a two-week history of cent...
Ulcerative colitis (UC) is a chronic systemic inflammatory condition primarily involving the large b...
Ulcerative colitis (UC) is a chronic inflammatory disease that predominantly affects the gastrointes...
AbstractMesalamine has been successfully used as a maintenance treatment in inflammatory bowel disea...
Extraintestinal manifestations are common complications of inflammatory bowel disease (IBD) whereas ...
Pericarditis is a known complication of mesalazine in the treatment of ulcerative colitis. This case...
Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with infla...
Abstract Background Myocarditis is a rare complication of therapy with mesalazine, a drug widely pre...
Copyright © 2015 Michele Sorleto et al.This is an open access article distributed under the Creative...
Ulcerative colitis is a chronic inflammatory disease affecting mainly the colon and presenting with ...
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first...
Inflammatory bowel diseases such as ulcerative colitis (UC) may be complicated by several extraintes...
Inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, may be associated wit...
Myocarditis can be idiopathic or arise in response to numerous systemic insults. Myocarditis occurri...
Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoi...
A 25-year-old male with a background of ulcerative colitis presented with a two-week history of cent...
Ulcerative colitis (UC) is a chronic systemic inflammatory condition primarily involving the large b...
Ulcerative colitis (UC) is a chronic inflammatory disease that predominantly affects the gastrointes...
AbstractMesalamine has been successfully used as a maintenance treatment in inflammatory bowel disea...
Extraintestinal manifestations are common complications of inflammatory bowel disease (IBD) whereas ...
Pericarditis is a known complication of mesalazine in the treatment of ulcerative colitis. This case...
Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with infla...
Abstract Background Myocarditis is a rare complication of therapy with mesalazine, a drug widely pre...
Copyright © 2015 Michele Sorleto et al.This is an open access article distributed under the Creative...
Ulcerative colitis is a chronic inflammatory disease affecting mainly the colon and presenting with ...
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first...